与 «KALLIKREIN»相关的英语书籍
在以下的参考文献中发现
kallikrein的用法。与
kallikrein相关的书籍以及同一来源的简短摘要提供其在 英语文献中的使用情境。
1
Regulation of
Kallikrein 6 Gene Expression and Protein ...
Colon cancer occurs in over 150,000 men and women in the United States each year and is fatal about one third of the time.
Rebecca Sue Henkhaus, 2008
2
Advanced Therapy in Cardiac Surgery
Surgical Procedure CPB Humoral Inflammatory Systems • Coagulation •
Kallikrein • l-jhrinolysis • Complement Cellular Activation • Neutrophils •
Monocytes • ilndothelial cells • Platelets Inflammatory Mediators • Cytokines •
Chemokines ...
3
Activation Profiles and Regulatory Cascades of the Human ...
Much recent work has been devoted to elucidating the potential for activation cascades between members of the KLK family, with physiologically relevant KLK regulatory cascades now described in skin desquamation and semen liquefaction.
4
Molecular Biology and Biotechnology: A Comprehensive Desk ...
Since the new T-kininogen gene product was no longer susceptible to cleavage
by kallikrein to yield kinins and also not able to participate as a cofactor in the
blood coagulation cascade, it has been proposed that T-kininogen expression ...
5
Principles and Practice of Endocrinology and Metabolism
The renal kallikrein-kinin system, the activity of which appears to be interrelated
with the RAS and prostaglandins, may participate in the control of RBF and
function by altering the tone of renal and extrarenal blood vessels, and by directly
...
6
The Role of Mast Cells and Plasma
Kallikrein in Mammary ...
Chapter 6 Future Directions The work presented in this thesis establishes the
importance of plasma kallikrein (PKal) in plasminogen activation in the mammary
gland during involution (Chapter 3) as well as identifies a role for mast cells in ...
Jennifer Noel Lilla, 2008
7
Asthma and COPD: Basic Mechanisms and Clinical Management
The historical name, “kallikrein”, is still used to refer to the most physiologically
important kininogenases from blood (plasma kallikrein) and from the major
exocrine organs (tissue, or glandular, kallikrein).This shared nomenclature is ...
Peter J. Barnes, Jeffrey M. Drazen, Stephen I. Rennard, 2002
8
Renin Angiotensin System and Cardiovascular Disease
Together with HMWK and Hageman factor, plasma kallikrein is involved in
coagulation, fibrinolysis, and possibly activation of the complement system. The
plasma kallikrein-HMWK system, acting through the release of bradykinin, could
be ...
Walmor C. DeMello, Edward D. Frohlich, 2009
9
Pharmaceutical Chemistry of Antihypertensive Agents
The amino acid sequence of glandular kallikrein from the guinea pig prostate
was investigated by Dunbar et al.235 The extent of sequence identity with the
kallikrein family of Ser proteases was found to be greater than 60%. This
substance is ...
Gyorgy Szasz, Zsuzsanna Budvari-Barany, 1990
10
Encyclopedia of Cancer
When the first kallikrein (kallikrein 1) was discovered in 1930, the enzyme was
reported to have a hypotensive effect and be present at high concentrations in
the pancreas, the organ known as kallikreas in Greek. It is now known that
kallikrein ...
包含词语«KALLIKREIN»的新条目
找出国内和国际出版社所讨论的内容，以及词语
kallikrein在以下新条目的上下文中是如何使用的。
BioCryst Pharmaceuticals Short Interest Down 19.9% in June …
BCX4161 is an inhibitor of plasma kallikrein in development as an orally administered treatment for the prevention of attacks with Hereditary ... «Mideast Time, 七月 15»
Dyax Corp. Short Interest Down 25.0% in June (DYAX)
Plasma kallikrein, an enzyme found in blood, produces bradykinin, a protein that causes blood vessels to enlarge or dilate, which can cause ... «sleekmoney, 七月 15»
Dyax Corp. (NASDAQ:DYAX), Cerner Corporation (NASDAQ:CERN)
... identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediated (PKM) disorders. «wsnewspublishers, 七月 15»
Biotech Stocks with Pessimistic Trend - Actinium Pharmaceuticals …
... identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediated (PKM) disorders. «Wall Street Observer, 七月 15»
Anti-Thrombin III Testing Market – Global Industry Analysis, Size …
... inhibitor that inhibits the production of thrombin and other activated serine protease coagulation systems such as factor Xa, IXa and kallikrein. «Medgadget.com, 七月 15»
BioCryst Pharmaceuticals Short Interest Down 19.9% in June (BCRX)
BCX4161 is an inhibitor of plasma kallikrein in development as an orally administered treatment for the prevention of attacks with Hereditary Angioedema (HAE). «Dakota Financial News, 七月 15»
Premarket Biotech Digest: JNJ Earnings, Celgene Making Deals …
(NASDAQ:DYAX) received a BTD for its candidate DX-2930, an mAb inhibitor of plasma kallikrein (pKal) given as a subcutaneous injection, ... «Seeking Alpha, 七月 15»
Zacks Downgrades BioCryst Pharmaceuticals to Sell (BCRX)
BCX4161 is an inhibitor of plasma kallikrein in development as an orally administered treatment for the prevention of attacks with Hereditary ... «WKRB News, 七月 15»
Top News: Dyax (NASDAQ:DYAX), MGIC Investment (NYSE:MTG …
Dyax is developing DX-2930, an investigational fully human monoclonal antibody inhibitor of plasma kallikrein (pKal), as a subcutaneous ... «Stock Transcript, 七月 15»
BioCryst Pharmaceuticals Lowered to Sell at Zacks (BCRX)
BCX4161 is an inhibitor of plasma kallikrein in development as an orally administered treatment for the prevention of attacks with Hereditary Angioedema (HAE). «Dakota Financial News, 七月 15»
